- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05618899
Effect of Exercises on Physical Health and Cardiorespiratory Fitness in Obese Women
Effect oh High Intensity Interval Training Versus Moderate Intensity Exercises on Physical Health and Cardiorespiratory Fitness in Obeses Women
The study will be a Randomized clinical trial and will be conducted in services hospital lahore. The sample size of 50 patients will be taken in this study to find the effects of high intensity interval training versus moderate intensity exercises on physical health and cardiorespiratory fitness in obese women.
Patients will be divided into two groups (Group A will be treated with high intensity interval training and Group B will be treated with moderate intensity exercises). Eligible participants attended three session per week. Overnight fast, resting metabolic rate and blood pressure will be assessed. An oral glucose test will be assessed and baseline blood samples will be used for lipoprotein analysis. Pacer test and step test performed in the each session. A regular follow-up visits to department and a final assessment will be made at the end of last week by using questionnaire and resulting improvement will shown in results after completion. Data will be analyzed on SPSS 25.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will be a Randomized clinical trial and will be conducted in services hospital lahore. The study will be completed within the duration of ten months. Non probability convenient sampling study technique will be used to collect the data. The sample size of 50 patients will be taken in this study to find the effects of high intensity interval training versus moderate intensity exercises on physical health and cardiorespiratory fitness in obese women.
Patients will be divided into two groups (Group A will be treated with high intensity interval training and Group B will be treated with moderate intensity exercises). Eligible participants attended three session per week. Overnight fast, resting metabolic rate and blood pressure will be assessed. An oral glucose test will be assessed and baseline blood samples will be used for lipoprotein analysis. Pacer test and step test performed in the each session. A regular follow-up visits to department and a final assessment will be made at the end of last week by using questionnaire and resulting improvement will shown in results after completion. Data will be analyzed on SPSS 25.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 54000
- Recruiting
- Ittefaq Hospital
-
Contact:
- madiha younas, MS
- Phone Number: 0333-8148025
- Email: madiha.younas@riphah.edu.pk
-
Sub-Investigator:
- Maham athar, MSCPPT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Women between the ages of 17-30 years
- BMI 25-35kg/m2.
- Sedentary (< 30 minutes of structured activity per week)
- Normal glucose tolerance ( fasting glucose <100mg/dL)
- No use of medications known to affect body composition or metabolism
- All participants will be non smoker
- No MI history
- No previous surgery.
- Free from known injury or known clinical conditio
Exclusion Criteria:
- BMI < 30 kg/m2 Known clinical condition including family history of sudden death, uncontrolled hypertension, type 1 and type 2 diabetes and cardiovascular diesease. • Participants will be excluded if they report in competitive exericise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HIGH INTENSITY INTERVAL TRAINING
High intensity interval training basicaaly short bursts of intense exercise alternating with low intensity recovery periods.
Training should be done on treadmill for 25-30 minutes.. Training proceed for 1 month once a day
|
Training should be done on treadmill for 25-30 minutes.. Training proceed for 1 month once a day
|
|
Experimental: MODERATE INTENSITY EXERCISE
moderate intensity exercises consist of generally 30-60 minutes of aerobic exercises at 64-76% of peak heart rate.
Training should be done on treadmill for 30-60 minutes.
Training proceed for 1 month once a day
|
moderate intensity exercises consist of generally 30-60 minutes of aerobic exercises at 64-76% of peak heart rate.
Training should be done on treadmill for 30-60 minutes.
Training proceed for 1 month once a day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Step test
Time Frame: 4weeks
|
the step test is designed to measured a person's aerobic fitness.
Participants steps up and down, on and off, an aerobics- type step for three minutes to increase heart rate and to evaluate the heart's recovery rate during the minute immediately following the step test exercise.
|
4weeks
|
|
Glucose tolerance test
Time Frame: 4weeks
|
The glucose tolerance test is a medical test in which glucose is given and blood samples taken afterward to determine how quickly it is cleared from the blood.
The test is usually used to test for diabetes, insulin resistance.
an oral glucose tolerance test (OGTT), a standard dose of glucose is ingested by mouth and blood levels are checked two hours later.
|
4weeks
|
|
Lipoprotein blood test:
Time Frame: 4weeks
|
lipoprotein test measures the level of lipoprotein in your blood. Lipoproteins are substances made of protein and fat that carry cholesterol through your bloodstream. Lipoprotein (a) is a type of LDL (bad) cholesterol. A high level of lipoprotein (a) may mean you are at risk for heart disease. |
4weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: madiha younas, MS, Riphah Internationl University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- REC/22/0343 MAHAM ATHAR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.